Shares of Extendicare Inc. (TSE:EXE – Get Free Report) have been assigned an average rating of “Buy” from the eight ratings firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, four have issued a buy recommendation and three have assigned a strong buy recommendation to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is C$23.86.
Several equities research analysts recently weighed in on EXE shares. CIBC raised their price objective on Extendicare from C$18.00 to C$22.00 in a report on Thursday, November 13th. Cormark lifted their price target on Extendicare from C$25.00 to C$30.00 in a research note on Wednesday, December 3rd. Royal Bank Of Canada upgraded Extendicare from a “hold” rating to a “moderate buy” rating and boosted their price target for the stock from C$15.00 to C$25.00 in a report on Thursday, December 4th. TD Securities raised their price objective on shares of Extendicare from C$15.00 to C$19.00 in a report on Thursday, November 13th. Finally, Natl Bk Canada raised shares of Extendicare to a “strong-buy” rating in a report on Wednesday, December 3rd.
Check Out Our Latest Analysis on EXE
Extendicare Price Performance
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Articles
- Five stocks we like better than Extendicare
- The day the gold market broke
- Forget AI, This Will Be the Next Big Tech Breakthrough
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Gold’s getting scarce.
- End of America Update
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
